Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 01, 2025 08:00 ET | Source: Cancer Focus Fund; ImmunoGenesis

ImmunoGenesis Expands Phase 1a/b Trial of IMGS-001 for Advanced Solid Tumors to Ochsner MD Anderson Cancer Center

The Phase 1 trial of IMGS-001-a novel dual-specific PD-L1/PD-L2 antibody with cytotoxic killing function-is expanding to Ochsner MD Anderson Cancer Center.
October 23, 2018 09:15 ET | Source: Precipio, Inc.

Precipio Expands ICE COLD-PCR™ Menu for Breast, Colon and Endometrial Cancers

Ultra-sensitive assays for PIK3CA exons 9 & 20 detect mutations that impact critical therapeutic decisions NEW HAVEN, Conn., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO),...
October 18, 2018 07:36 ET | Source: Precipio, Inc.

Innovation Behind Precipio’s ICE-COLD PCR™ Platform Spotlighted in Media

Articles Highlight Scientific and Economic Advantages Provided by Precipio’s Technology NEW HAVEN, Conn., Oct. 18, 2018 (GLOBE NEWSWIRE) -- The scientific and economic advantages of the...
September 20, 2018 07:37 ET | Source: Precipio, Inc.

Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering

New kit examines most relevant EGFR exons that impact therapeutic decisions for lung cancer patients NEW HAVEN, Conn., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO), announced...
June 06, 2018 07:38 ET | Source: Precipio, Inc.

Precipio Strengthens Patent Portfolio with Expanded Kit Claims for its Liquid Biopsy Enabling DNA Mutation Enrichment Technology

NEW HAVEN, Conn., June 06, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO), today announced the award of US patent No. 9,957,556 entitled FULL COLD-PCR...